DISCOUNT ZERTIFIKAT - ABBVIE Share Price

Certificat

DE000ME67XE5

Market Closed - Börse Stuttgart 12:57:57 01/06/2024 am IST
108.9 EUR +0.11% Intraday chart for DISCOUNT ZERTIFIKAT - ABBVIE
Current month-0.93%
1 month-0.93%
Date Price Change
31/24/31 108.9 +0.11%
30/24/30 108.8 -0.24%
29/24/29 109 +0.68%
28/24/28 108.3 -0.15%
27/24/27 108.4 -0.18%

Delayed Quote Börse Stuttgart

Last update May 01, 2024 at 12:57 am IST

More quotes

Static data

Product typeDiscount-Zertifikate
Buy / SellCALL
Underlying ABBVIE INC.
Issuer Morgan Stanley
WKN ME67XE
ISINDE000ME67XE5
Date issued 02/01/2024
Maturity 20/09/2024 (112 Days)
Parity 1 : 1
Emission price 105
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 110.1
Lowest since issue 103.2
Spread 0.01
Spread %0.01%

Company Profile

AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (77.1%), Germany (2.3%), Canada (2%), Japan (1.9%), China (1.7%), France (1.4%), Spain ( 0.9%), Italy (0.9%), Australia (0.9%), Brazil (0.8%), United Kingdom (0.8%) and others (9.3%).
Sector
-
More about the company

Ratings for AbbVie Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: AbbVie Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
161.2 USD
Average target price
182.1 USD
Spread / Average Target
+12.95%
Consensus